1RC

CREO MEDICAL GRP LS-001

Healthcare · EUR · F

1RC

Price

€0.157

+26.61%

Cap

€53.62M

Earnings

30d Trend

+10.6%

1RC
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

76% annualised over 90 days

BRAIN47 SIGNAL

0
WEAK
Risk Level80
Quality37
Momentum42
Technical69
Fundamentals18

Raw weighted: 36×Macro 0.99 (1%)=36

RISK

80/100
90d Volatility
76.3%High
ATR %
6.7%High daily moves
Max Drawdown (1Y)
-41.4%Volatile

QUALITY

37/100
ROE (avg)
-67.7%*Negative
Piotroski F-Score
3/9Weak
Debt/Equity
0.10Low leverage
Margin Stability
CV 55.2%Volatile

MOMENTUM

42/100
12-1M Momentum
-29.7%Strong downtrend
6-1M Momentum
+24.3%Positive
1M Return
+19.6%Strong recent gains
Relative Strength
+1.0% vs sectorIn-line

TECHNICAL

69/100
RSI (14)
68.9Neutral
Price vs SMA200
+17.8%Bullish trend
MACD
+0.28Bullish momentum
Bollinger Band
103%Near upper band
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.333Mixed

FUNDAMENTALS

18/100
P/S
13.4Expensive
Shareholder Yield
0.0%Low

Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months69
3-12 months63
1-5+ years24

Short-term opportunity — technical setup

BRAIN47'S ASSESSMENT

I rate CREO MEDICAL GRP LS-001 at 36/100 — a WEAK reading on the Brain47 Signal. The strongest factor is technical at 69/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

+19.6%

3 MONTHS

-4.1%

12 MONTHS

-10.1%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Short-term opportunity — technical setup. Technical (69) and Momentum (42) are the primary strengths. I note that fundamentals is the weakest area at 18/100 — this warrants monitoring. Historical volatility is elevated at 76%. I classify this as a speculative position — elevated volatility at 76% and smaller market cap define the opportunity.

speculativeScore: 36/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.